Follow
Julio Cesar Zuniga Moya
Julio Cesar Zuniga Moya
Verified email at wustl.edu
Title
Cited by
Cited by
Year
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA. 2
R Uraki, M Kiso, S Iida, M Imai, E Takashita, M Kuroda, PJ Halfmann, ...
Nature 607 (7917), 119-127, 2022
2232022
HIT-COVID, a global database tracking public health interventions to COVID-19
Q Zheng, FK Jones, SV Leavitt, L Ung, AB Labrique, DH Peters, EC Lee, ...
Scientific data 7 (1), 286, 2020
1082020
Perfil de sensibilidad a los antibióticos de las bacterias en infecciones del tracto urinario
JC Zúniga-Moya, S Bejarano-Cáceres, H Valenzuela-Cervantes, ...
Acta Médica Costarricense 58 (4), 146-154, 2016
48*2016
The geographic distribution of dimorphic mycoses in the United States for the modern era
PB Mazi, JM Sahrmann, MA Olsen, A Coler-Reilly, AM Rauseo, M Pullen, ...
Clinical Infectious Diseases 76 (7), 1295-1301, 2023
462023
Clinical spectrum of severe acute respiratory syndrome coronavirus 2 infection and protection from symptomatic reinfection
HE Maier, G Kuan, S Saborio, FAB Carrillo, M Plazaola, C Barilla, ...
Clinical Infectious Diseases 75 (1), e257-e266, 2022
392022
A dengue outbreak in a rural community in Northern Coastal Ecuador: An analysis using unmanned aerial vehicle mapping
GO Lee, L Vasco, S Márquez, JC Zuniga-Moya, A Van Engen, J Uruchima, ...
PLoS neglected tropical diseases 15 (9), e0009679, 2021
192021
Unexplored Genetic Diversity of Multidrug- and Extremely Drug-Resistant Acinetobacter baumannii Isolates from Tertiary Hospitals in Honduras
G López-Leal, JC Zuniga-Moya, S Castro-Jaimes, L Graña-Miraglia, ...
Microbial Drug Resistance 25 (5), 690-695, 2019
182019
Implementation of Rapid Diagnostics Assays for Detection of Histoplasmosis and Cryptococcosis in Central American People Living with HIV
DH Caceres, AB Arauz, C Flores, E Santiago, S Montoya, C Saenz, ...
Mycoses, 2021
142021
Epidemiology, outcomes and associated factors of COVID-19 RT-PCR confirmed cases in the San Pedro Sula Metropolitan Area, Honduras
JC Zuniga-Moya, DA Norwood, LE Romero Reyes, E Barrueto Saavedra, ...
Clin Infect Dis 10, 2020
92020
Antimicrobial profile of Acinetobacter baumannii at a tertiary hospital in Honduras: a cross-sectional analysis
JC Zuniga-Moya, CA Caballero, M Loucel-Linares, MJ Benitez, ...
Revista Panamericana de Salud Pública 44, 2020
92020
Feasibility of a symptom management intervention for Honduran adults undergoing chemotherapy
S Bejarano, ME Freed, D Zeron, R Medina, JC Zuniga-Moya, L Kennedy, ...
Western Journal of Nursing Research 41 (10), 1517-1539, 2019
52019
A chikungunya outbreak in a dengue-endemic region in rural northern coastal Ecuador
S Márquez, GO Lee, P Andrade, J Zuniga, G Trueba, JNS Eisenberg, ...
The American Journal of Tropical Medicine and Hygiene 107 (6), 1226, 2022
32022
Prevalence of Cryptococcal antigen and outcomes in people with human immunodeficiency virus in Honduras: a cohort study
JC Zuniga-Moya, LE Romero-Reyes, EB Saavedra, S Montoya, D Varela, ...
Open Forum Infectious Diseases 8 (1), ofaa557, 2021
32021
Feasibility of brigade-style, multiphasic cancer screening in rural Honduras
KD Lyons, LS Kennedy, EPM Larochelle, GJ Tsongalis, HS Reyes, ...
JCO Global Oncology 6, 453-461, 2020
32020
Reducing dermal exposure to agrochemical carcinogens using a fluorescent dye-based intervention among subsistence farmers in rural Honduras
TG Flynn, CMD Altamirano, HSR García, RJB Campos, JCZ Moya, ...
Journal of Global Oncology, 10s-10s, 2018
12018
Incidence and Mortality of COVID-19-Associated Invasive Fungal Infections Among Critically Ill Intubated Patients: A Multicenter Retrospective Cohort Analysis
JC Zuniga-Moya, B Papadopoulos, AER Mansoor, PB Mazi, AM Rauseo, ...
Open Forum Infectious Diseases 11 (4), ofae108, 2024
2024
The effect of limited healthcare access on poor outcomes among hospitalized COVID-19 patients in Honduras: A single center cohort study
C Alas-Pineda, D Aguilar-Andino, FAV Munguia, GMP David, AN Umaña, ...
Heliyon 10 (1), 2024
2024
2883. Comparative outcomes following Candida bloodstream infections in patients with left ventricular assist devices (LVAD)
AR Mansoor, G Krishnan, JC Zuniga-Moya, D Sinclair, A Spec, I George
Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 160, 2023
2023
Comparación del tratamiento combinado con bifonazol a 1% más urea a 40%, monoterapia con urea a 40% y placebo en pacientes con onicomicosis.
JF JE, TO JN, FA ME, CM CG, AC AK, PV EC, MB IE, ZM JC
Dermatologia Revista Mexicana 62 (1), 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–19